Researcher
Koen Van Laere
- Disciplines:Medical imaging and therapy, Medicinal products
Affiliations
- Nuclear Medicine & Molecular Imaging (Division)
Responsible
From1 Oct 2012 → Today - Nuclear Medicine & Molecular Imaging (Division)
Member
From1 Oct 2002 → Today
Infrastructure
1 - 3 of 3
- simultaneous time-of-flight PET-MR scanner (Consortium coordinator)
- Flanders BioImaging: towards an integrated, translational and multimodal imaging platform from molecule to man. (Consortium coordinator)
- FB-III (“FB triple-I”) : Flanders BioImaging: Integrating Imaging Infrastructure from cell to man. (Consortium coordinator)
Projects
1 - 10 of 51
- Prospective clinical diagnostic performance of the novel fibroblast imaging tracer 18F-AlF-FAPI-74 versus standard of care 18F-FDG PET/CT in inflammatory disorders and fever/inflammation of unknown origin.From16 Apr 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Towards mechanistic biomarkers for amyotrophic lateral sclerosisFrom1 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Prospective head-to-head comparison of cardiac [18F]-MFBG PET versus [123I]-MIBG SPECT in the differentiation between Parkinson’s disease and multiple system atrophy and between dementia with Lewy bodies and Alzheimer’s disease.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- In vivo PET of synaptic density in cognitive disorders: prospective evaluation of neuronal dysfunction and relation to symptomatology.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- [18F]-MFBG PET of the cardiac noradrenergic system for early differentiation in Parkinson’s disease and dementia with Lewy bodies.From1 Oct 2023 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Flanders BioImaging: Leading Imaging Application Integrated Service and Enablement (FBI-LIAISE)From1 Jan 2023 → TodayFunding: FWO International research infrastructure (IRI)
- IMAGINATION : IMAGing bIomarkers for diagNosis, therAnosTIcs and drug develOpmeNtFrom1 Oct 2022 → TodayFunding: IOF - mandates
- A multi-modal approach to study C9orf72-mediated diseaseFrom16 May 2022 → 15 May 2023Funding: BOF - postdoctoral mandates
- Innovative concepts for PET-MR imaging of brain function and brain-gut interactionsFrom14 Jan 2022 → TodayFunding: BOF - doctoral mandates
- In vivo PET of synaptic density as potential diagnostic marker for AD and DLB: Prospective comparison with current imaging markers for neuronal dysfunction and relation to symptomatologyFrom1 Jan 2022 → TodayFunding: Private funding of national origin - undefined
Publications
41 - 50 of 451
- [18F]PSMA-1007 PET/CT in the detection of neoplastic lumbosacral plexopathy as an emerging and underestimated spread of prostate cancer(2022)
Authors: Niloefar Ahmadi Bidakhvidi, Koen Van Laere, Gert De Meerleer, Karolien Goffin
Pages: 3950 - 3951 - Classification of 18F-Flutemetamol scans in cognitively normal older adults using machine learning trained with neuropathology as ground truth(2022)
Authors: Mariska Reinartz, Emma Luckett, Jolien Schaeverbeke, Steffi De Meyer, Dietmar Thal, Koen Van Laere, Patrick Dupont, Rik Vandenberghe
Pages: 3772 - 3786 - Synaptic density in cortical and subcortical gray matter is associated with mild parkinsonian signs (MPS) in healthy older adults: a [11C] UCB-J PET study(2022)
Authors: Aline Delva, Ahmed Radwan, Maarten Laroy, Koen Van Laere, Filip Bouckaert, Mathieu Vandenbulcke
Pages: S39 - S40 - Impact of meningeal uptake and partial volume correction techniques on [18F]MK-6240 binding in aMCI patients and healthy controls(2022)
Authors: Laura Michiels, Greet Vanderlinden, Mathieu Vandenbulcke, Robin Lemmens, Koen Van Laere, Michel Koole
Pages: 1236 - 1246 - THE PATTERN OF JOINT INFLAMMATION IN THE CAIA MOUSE MODEL OF ARTHRITIS(2022)
Authors: Margot Van Mechelen, Koen Van Laere, Rik Lories, Barbara Neerinckx
Pages: 1184 - 1184 - Phospho-specific plasma p-tau181 assay detects clinical as well as asymptomatic Alzheimer's disease(2022)
Authors: Steffi De Meyer, Jolien Schaeverbeke, Mariska Reinartz, Emma Luckett, Patrick Dupont, Koen Van Laere, Koen Poesen, Rik Vandenberghe
Pages: 734 - 746 - Value of [68Ga]Ga-somatostatin receptor PET/CT in the grading of pulmonary neuroendocrine (carcinoid) tumours and the detection of disseminated disease: single-centre pathology-based analysis and review of the literature(2022)
Authors: Annouschka Laenen, Birgit Weynand, Christophe Dooms, Walter De Wever, Karolien Goffin, Johan Vansteenkiste, Koen Van Laere, Paul De Leyn, Kristiaan Nackaerts, Christophe Deroose
- Predictive value of metabolic and perfusion changes outside the seizure onset zone for postoperative outcome in patients with refractory focal epilepsy(2022)
Authors: Evy Cleeren, Patrick Dupont, Johan van Loon, Tom Theys, Koen Van Laere, Wim Van Paesschen, Karolien Goffin
Pages: 325 - 335 - Neuroinflammation as potential precursor of leukoencephalopathy in early-stage breast cancer patients: A cross-sectional PET-MRI study(2022)
Authors: Gwen Schroyen, Charlotte Sleurs, Koen Van Laere, Ann Smeets, Sabine Deprez, Stefan Sunaert
Pages: 61 - 68 - Increased Uptake of 18F-PSMA-1007 in Corpus Luteum Demonstrated by PET/CT(2022)
Authors: Karolien Goffin, Koen Van Laere, Christophe Deroose
Pages: E331 - E332